Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing
Ziwen Zheng, Li Guo, Chong Cui, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Advances in gene therapy hold promise for treating hereditary hearing loss
Luoying Jiang, Daqi Wang, Yingzi He, et al.
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 934-950
Open Access | Times Cited: 69
Deafness: from genetic architecture to gene therapy
Christine Petit, Crystel Bonnet, Saaïd Safieddine
Nature Reviews Genetics (2023) Vol. 24, Iss. 10, pp. 665-686
Open Access | Times Cited: 61
Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse model
Hui Wang, Mengzhao Xun, Honghai Tang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102135-102135
Open Access | Times Cited: 11
RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models
Yingqi Lin, Caijuan Li, Yizhi Chen, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss
Chong Cui, Daqi Wang, Bowei Huang, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 400-412
Open Access | Times Cited: 34
Preclinical Efficacy And Safety Evaluation of AAV‐OTOF in DFNB9 Mouse Model And Nonhuman Primate
Jieyu Qi, Liyan Zhang, Fangzhi Tan, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 22
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins
M. Alejandra Zeballos C., Hayden J. Moore, Tyler Smith, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Is there an unmet medical need for improved hearing restoration?
Bettina Wolf, Kathrin Kusch, Victoria Hunniford, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 25
Advancements and future prospects of adeno-associated virus-mediated gene therapy for sensorineural hearing loss
Linke Li, Tian Shen, Shixi Liu, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Programmable RNA targeting with CRISPR-Cas13
Peiguo Shi, Xuebing Wu
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-9
Open Access | Times Cited: 5
RISC-y Business: Limitations of Short Hairpin RNA-Mediated Gene Silencing in the Brain and a Discussion of CRISPR/Cas-Based Alternatives
Kanishk Goel, Jonathan E. Ploski
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 19
Approaches and Vectors for Efficient Cochlear Gene Transfer in Adult Mouse Models
Yu Zhao, Longlong Zhang, Daqi Wang, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 38-38
Open Access | Times Cited: 19
Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges
Roni Hahn, Karen B. Avraham
Audiology Research (2023) Vol. 13, Iss. 6, pp. 952-966
Open Access | Times Cited: 11
Engineering of the AAV-Compatible Hair Cell-Specific Small-Size Myo15 Promoter for Gene Therapy in the Inner Ear
Shao Wei Hu, LV Jun, Zijing Wang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 4
An engineered adeno-associated virus mediates efficient blood-brain barrier penetration with enhanced neurotropism and reduced hepatotropism
Nengsong Luo, Kunzhang Lin, Yuxiang Cai, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 303-315
Open Access
Advancing precision ear medicine: leveraging animal models for disease insights and therapeutic innovations
Sandrine Vitry, Clara Mendia, Audrey Maudoux, et al.
Mammalian Genome (2025)
Open Access
Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing Loss
Joey Lye, Derek S. Delaney, Fiona K. Leith, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3347-3347
Open Access | Times Cited: 9
Advancements in inner ear development, regeneration, and repair through otic organoids
Carl Nist-Lund, Jin Kim, Karl R. Koehler
Current Opinion in Genetics & Development (2022) Vol. 76, pp. 101954-101954
Open Access | Times Cited: 14
Extracellular vesicles for developing targeted hearing loss therapy
Xiaoshu Pan, Yanjun Li, Peixin Huang, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 460-478
Closed Access | Times Cited: 2
Characterization of RNA editing and gene therapy with a compact CRISPR-Cas13 in the retina
Satheesh Kumar, Yi-Wen Hsiao, Vickie Wong, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 45
Closed Access | Times Cited: 2
Progress in and Prospects of Genome Editing Tools for Human Disease Model Development and Therapeutic Applications
Phan Thi Lam Hong, Kyoungmi Kim, Ho Lee, et al.
Genes (2023) Vol. 14, Iss. 2, pp. 483-483
Open Access | Times Cited: 6
A base editor for the long-term restoration of auditory function in mice with recessive profound deafness
Chong Cui, Shengyi Wang, Daqi Wang, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 2
CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing Loss
Xiaoshu Pan, Peixin Huang, Samantha Ali, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Genetic correction of induced pluripotent stem cells from a DFNA36 patient results in morphologic and functional recovery of derived hair cell-like cells
Yi Luo, Kaiwen Wu, Xiaolong Zhang, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
CRISPR–Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics
Guanglin Zhu, Xinzhi Zhou, Mingzhang Wen, et al.
BioDesign Research (2024) Vol. 6
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top